What is the recommended dose of Pradaxa for atrial fibrillation (AFIB)?

[Admin]

What is the recommended dose of Pradaxa for atrial fibrillation (AFIB)?​

Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation For patients with creatinine clearance (CrCl) >30 mL/min, the recommended dose of PRADAXA is 150 mg taken orally, twice daily.

What is Pradaxa?​

Boehringer Ingelheim Pharmaceuticals, Inc. What is PRADAXA? Pradaxa ® (dabigatran etexilate) is a prescription medicine that is used to: reduce the risk of stroke and blood clots in adults who have a medical condition called atrial fibrillation that is not caused by a heart valve problem.
Pradaxa (dabigatran) is an anticoagulant that works by blocking the clotting protein thrombin. Pradaxa is used to prevent blood clots from forming because of a certain irregular heart rhythm (atrial fibrillation). Preventing these blood clots helps to reduce the risk of a stroke.
Is pradpradaxa a good alternative to warfarin?
PRADAXA was the first alternative to warfarin approved by the FDA to reduce the risk of stroke due to AFib not caused by a heart valve problem. See how the two compare. The most important way to reduce your risk of ischemic stroke due to AFib is by reducing the chance of blood clots forming

Does Pradaxa have a higher mi rate than warfarin in NVAF?
In NVAF patients, a higher rate of clinical MI was reported in patients who received PRADAXA (0.7/100 patient-years for 150 mg dose) than in those who received warfarin (0.6).

Can you take Pradaxa if you have mechanical heart valve problems?​

Pradaxa is not indicated for patients with atrial fibrillation caused by heart valve problems. Pradaxa is not approved for patients with atrial fibrillation caused by heart valve problems. FDA is requiring a contraindication (a warning against use) of Pradaxa in patients with mechanical heart valves.